Recombinant avian paramyxovirus vaccine and method for making and using thereof
US8486418B2 · kind B2 · utility
2Cited by
1References
32Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 20, 2010 |
| Grant date | Jul 16, 2013 |
| Priority date | — |
| Expiry date | Dec 6, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2999/007
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention encompasses engineered APMV compositions or vaccines. The vaccine or composition may be a recombinant APMV composition or vaccine. The present invention encompasses methods for modifying the genome of APMV to produce recombinant APMV; modified APMV prepared by such methods; DNA and protein sequences; and methods for infecting cells and host animals with such recombinant APMV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.